Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 16.55
+0.10 (0.61%)
At close: Jun 5, 2026
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €124.4 million as of June 5, 2026. Its market cap has increased by 401.00% in one year.
Market Cap
124.40M
Enterprise Value
122.20M
Revenue
9.69M
Ranking
n/a
PE Ratio
42.95
Stock Price
€16.55
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 124.40M, an increase of 709.42%. That is a compound annual growth rate of 64.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 124.40M | 93.37% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.55B |
| Laboratorios Farmaceuticos Rovi | 3.01B |
| Almirall | 2.41B |
| Pharma Mar | 1.67B |
| Oryzon Genomics | 232.07M |
| Prim, S.A. | 225.43M |
| Laboratorio Reig Jofre | 220.63M |
| Atrys Health | 209.88M |